@article {Chu:1 March 2001:1381-6128:i,
	author = "Chu, D.T.W.",
	title = "Preface",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 March 2001",
	pages = "i-i(1)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000005/art00001"
	doi = "doi:10.2174/1381612013397997"
}

@article {Bhanot:1 March 2001:1381-6128:311,
	author = "Bhanot, S.K.",
	author = "Singh, M.",
	author = "Chatterjee, N.R.",
	title = "The Chemical and Biological Aspects of Fluoroquinolones Reality and Dreams",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 March 2001",
	pages = "311-335(25)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000005/art00002"
	doi = "doi:10.2174/1381612013398059"
}

@article {Anderson:1 March 2001:1381-6128:337,
	author = "Anderson, V.E.",
	author = "Osheroff, N.",
	title = "Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 March 2001",
	pages = "337-353(17)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000005/art00003"
	doi = "doi:10.2174/1381612013398013"
}

@article {Williamson:1 March 2001:1381-6128:355,
	author = "Williamson, J.S.",
	title = "Helicobacter pylori Current Chemotherapy and New Targets for Drug Design",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 March 2001",
	pages = "355-392(38)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000005/art00004"
	doi = "doi:10.2174/1381612013397979"
}

@article {Arikan:1 March 2001:1381-6128:393,
	author = "Arikan, S.",
	author = "Rex, J.H.",
	title = "Lipid-based Antifungal Agents Current Status",
	journal = "Current Pharmaceutical Design",
	volume = "7",
	year = "1 March 2001",
	pages = "393-415(23)",
	url = {http://www.ingentaconnect.com/content/ben/cpd/2001/00000007/00000005/art00005"
	doi = "doi:10.2174/1381612013398031"
}